Delivery Order SPE2DB20D3103-SPE2DB23FL5M9
Award Date 11/7/22
Potential Completion Date 11/8/22
Potential Value $11K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $10,038.08, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,254,639 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a completion date of February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $12,952.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The contract has a firm fixed-price pricing type and an ultimate completion date of February 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $2,712.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,510,655 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. This is a firm fixed-price delivery order contract with a completion date of November 22, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award, valued at $17,009.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,665,266 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 4, 2024. It is not designated as a...
- This federal contract award, valued at $12,458.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,678 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of March 25, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract award, valued at $25,982.21, is for the delivery of 4,563,219,741 tablets of Ondansetron HCL 4 mg, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a completion date of January 4, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc.,...
- This federal contract award, valued at $1,855.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting, with an ultimate completion date of October 11, 2022. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $7,721.18, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,612,620 tablets of Ondansetron HCL 4 mg, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of December 5, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,648.59 firm-fixed-price delivery order is for the supply of 4 mg Ondansetron HCl tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of April 22, 2025 and is not set aside for any special type of business. AmerisourceBergen Drug Corp holds a substantial...
- This federal contract award, valued at $16,782.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,966,829 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant...